Moreover, HR+/HER2- and basal-like tumors are biologically more similar to triple-negative breast cancers, characterized by increased expression of cyclin E1, EGFR, and p16 and low expression of ER1, PGR1, and Forkhead box1. Here, ERBB2 is linked to triple-negative breast carcinoma.